HIV protease inhibitor ritonavir impairs endothelial function via reduction in adipose mass and endothelial leptin receptor‐dependent increases in NADPH oxidase 1 …
T Bruder‐Nascimento, TC Kress… - Journal of the …, 2020 - Am Heart Assoc
Background Cardiovascular disease is currently the leading cause of death in patients with
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor-Dependent Increases in NADPH …
T Bruder-Nascimento, TC Kress, S Kennard… - Journal of the …, 2020 - europepmc.org
Background Cardiovascular disease is currently the leading cause of death in patients with
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
[引用][C] HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor-Dependent Increases in NADPH …
T Bruder-Nascimento, TC Kress, S Kennard… - Journal of the …, 2020 - hero.epa.gov
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass
and Endothelial Leptin Receptor-Dependent Increases in NADPH Oxidase 1 (Nox1), CC …
and Endothelial Leptin Receptor-Dependent Increases in NADPH Oxidase 1 (Nox1), CC …
[HTML][HTML] HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in …
T Bruder‐Nascimento, TC Kress… - Journal of the …, 2020 - ncbi.nlm.nih.gov
Background Cardiovascular disease is currently the leading cause of death in patients with
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
Hiv protease inhibitor ritonavir impairs endothelial function via reduction in adipose mass and endothelial leptin receptor-dependent increases in nadph oxidase 1 …
T Bruder-Nascimento, TC Kress… - Journal of the …, 2020 - augusta.elsevierpure.com
BACKGROUND: Cardiovascular disease is currently the leading cause of death in patients
with human immunodeficiency virus on combination antiretroviral therapy. Although the use …
with human immunodeficiency virus on combination antiretroviral therapy. Although the use …
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor-Dependent Increases in NADPH …
T Bruder-Nascimento, TC Kress… - Journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Cardiovascular disease is currently the leading cause of death in patients with
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …